ORTEXORTEX News
Tracking CBRE? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CB
Earnings PreviewCBRE

CBRE Falls 7% in a Week as Options Traders Turn Defensive

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 26 Oct 2026, 04:01

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

CBRE has shed 7.3% over the past week and 12.6% over the past month, arriving at $123.30 ahead of its October 29 earnings release in notably worse shape than when analysts last updated their targets.

Options positioning tells the clearest story about how investors are leaning. Put demand has jumped sharply, pushing the put/call ratio to 1.06, the highest reading of the past year and nearly two standard deviations above its 20-day average of 0.91. That is not a crowded short: with just 1.5% of the free float short and borrow availability about as loose as it gets, there is no structural pressure in the lending market. The defensive tilt is coming through options, not through the short book. Cost to borrow has edged up 26% over the past month but remains trivially low at 0.40%, and availability has stayed pinned at the top of its range throughout October.

The analyst community has spent the past month quietly walking back numbers while keeping positive ratings intact. Evercore ISI trimmed its target to $166 from $168 on October 23, one day after the stock fell 8.4% following the most recent earnings release. KBW had already cut to $164 from $174 on October 9. The consensus mean now sits at $175.75, implying more than 40% upside from current levels, a gap that reflects how far the stock has fallen rather than a surge in analyst conviction. The fundamental debate has not shifted: bulls remain anchored to the outsourcing and fee-based revenue thesis, which is supposed to cushion CBRE through CRE cycles. Bears point to the valuation, where the stock was trading at 18 to 21 times forward earnings even before the recent slide, and to the risk that capital markets activity stays muted longer than the bull case assumes. The P/E has compressed to 14.2 times on trailing earnings as the stock has dropped, which either represents a genuine re-rating or a floor that depends entirely on the earnings trajectory holding up.

One data point worth noting: CBRE's buyback spend ran 56% above the prior year's second quarter at $410 million, and its remaining authorization rose 271% year-on-year to $5.2 billion as of the most recently filed quarter. That is a significant balance sheet commitment heading into a period where the stock is trading well below where management was buying. The question the October 29 print is set to answer is whether the operating results justify that capital allocation, or whether the recent sell-off reflects something more fundamental about conditions in the commercial real estate services market that the fee-mix thesis has not yet absorbed.

Stocks in this article

See the live data behind this article on ORTEX.

Open CBRE on ORTEX →

How this article was generated

Generated
26 Oct 2026, 04:22
Data as of
26 Oct 2026, 04:01
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
Validation notes
  • soft: missing section mentions: short interest (informational only)

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.